BioSpace News Archive

The global Artificial Neural Network (ANN) market size was USD 160.8 Million in 2021 and register a revenue CAGR of 18.7% over the forecast period, according to a latest analysis by Emergen Research.

The global orthopedics diagnostic devices market size reached USD 11,024.00 Million in 2021 and is expected to register a revenue CAGR of 3.9% during the forecast period, according to latest analysis by Emergen Research

The global nebulizers market size was USD 1.12 Billion in 2021 and is expected to register a revenue CAGR of 7.6% during the forecast period, according to latest analysis by Emergen Research.

The global microarray market size was USD 3.99 Billion in 2021 and is expected to register a revenue CAGR of 8.31% during the forecast period, according to latest analysis by Emergen Research.

The global lipid nanodiscs market is expected to witness a robust CAGR during the forecast period. The growth of this market is attributed to the increasing demand for lipid nanodiscs in healthcare and pharmaceutical applications

Halberd Corporation (OTC Pink: HALB) This past quarter has witnessed some very significant technical and organizational achievements by the Halberd team.

Endogena Therapeutics Inc. announced today that the first patient has been treated in a phase 1/2a clinical study of its lead product, EA-2353, a photoreceptor regeneration treatment for retinitis pigmentosa (RP).

VisionHealth and Boehringer Ingelheim will cooperate on the Kata® app for therapy support in asthma and chronic obstructive pulmonary disease (COPD).

Elixiron Immunotherapeutics, a clinical stage drug development company announced today that it has received a new grant from the Alzheimer’s Association Part the Cloud program to accelerate the application of EI-1071, a novel orally-administered immunomodulatory therapy for people with Alzheimer’s disease.

A team at NYU Langone Health successfully transplanted two genetically engineered pig hearts into recently deceased humans in June and July, marking the latest advances toward addressing the nationwide organ shortage and developing a clinical protocol that would provide an alternative supply of organs for people with life-threatening heart disease.